Forecasting for Life Sciences
Work with precise models and custom forecasts to project the future potential of medicine.

Want to learn more?


Our forecasts mirror the realities of the marketplace so you have defendable forecasts that enable confident decision making. We have the competency and experience to deliver when precision, speed and understanding cannot be compromised.

Key features

Quantifying future potential with confidence

Forecasting, epidemiology, scientific and access teams work seamlessly to produce comprehensive, defendable forecasts.

Preparing for competitive events

Anticipate and plan for changes in diagnosis and treatment rates, new product launches and market expansion.

User-friendly models that adapt with your market

Alter assumptions and add model segments while tracking patients across disease stages or lines of therapy.

More information
Our forecasting solutions are rigorous, timely, integrated, detailed and global. We go beyond a simple trending of prescription sales and unit volume to deliver custom market models that reflect the complexities of the market, integrate with your data sources, and support your reporting requirements.
Our staff, tools and methodologies are seamlessly linked to provide forecasting solutions that suit every market need. Our team has extensive experience with programming and advanced methodologies including volumetric forecasts, patient flow models, and cross-sectional models.

Kantar recognises the importance of rare diseases in furthering patient care and understands the inherent challenges you face. Our forecasters and epidemiologists triangulate data sources and, working with our subject matter experts, incorporate Key Opinion Leader (KOL) input to accurately size patient populations and deliver defendable forecasts.

Forecasting for cancer treatments comes with unique challenges, including determining the correct number of patients, following them through lines of therapies and addressing various biomarkers and patient segments. Our deep understanding of cancer and proprietary data solutions ensure you get a comprehensive deliverable you can trust.

Related solutions
Strategic and tactical support to evaluate in/out licensing opportunities and the commercial potential for pharma assets.
A decision support resource for oncology market analysis, strategic planning and identifying commercial opportunities.
Identify and screen oncology development targets with breakthrough potential quickly, comprehensively and accurately.